FDA Approves AstraZeneca: In a significant stride forward in pediatric healthcare, the U.S. Food and Drug Administration (FDA) has given the green light to a new vaccine developed by AstraZeneca and Sanofi. This vaccine is designed to protect infants and toddlers against Respiratory Syncytial Virus (RSV), a leading cause of hospitalization among children less than a year old. “FDA approves AstraZeneca, Sanofi shot that protects … Continue reading FDA Approves AstraZeneca, Sanofi Shot to Shield Infants and Toddlers Against RSV!